Most Clicked StoriesMore >


Thiel associate Srinivasan reportedly considered for FDA chief

FDLI SmartBrief | Jan 17, 2017

Former biotech executive Balaji Srinivasan, an associate of venture capitalist Peter Thiel, is under consideration by President-elect Donald Trump to head the FDA, sources say. Srinivasan has been critical of the FDA, saying it has slowed scientific innovation. Bloomberg (01/13) The Hindu (India) (01/17)


Eisai receives FDA Form 483 over quality control issues

FDLI SmartBrief | Jan 13, 2017

Analysis: Orphan Drug Act being manipulated by some drugmakers

FDLI SmartBrief | Jan 18, 2017

Timing rule for biosimilar launches under Supreme Court review

FDLI SmartBrief | Jan 16, 2017

FDA finalizes guidance on naming of biologics and biosimilars

FDLI SmartBrief | Jan 13, 2017

E-cigarette firms see opportunity to ease oversight under new administration

FDLI SmartBrief | Jan 19, 2017

Biosimilar interchangeability draft guidance released by FDA

FDLI SmartBrief | Jan 18, 2017

Draft guidance released by FDA to speed up generics approvals, clear up terms

FDLI SmartBrief | Jan 16, 2017

FDA approves Teva's abuse-deterrent opioid

FDLI SmartBrief | Jan 19, 2017

Roxane Labs' generic narcolepsy treatment wins FDA nod

FDLI SmartBrief | Jan 18, 2017


Find FDLI SmartBrief Issues by Date:



FDLI News More >


Tobacco and Nicotine Delivery: Regulation and Compliance, 2nd Ed.

FDLI SmartBrief | Jan 20, 2017

The New to Food and Drug Law Group

FDLI SmartBrief | Jan 20, 2017

Introduction to US Food Law and Regulation, March 2-3, Washington, D.C.

FDLI SmartBrief | Jan 19, 2017

Webinar on-demand: 21st Century Cures Act

FDLI SmartBrief | Jan 19, 2017

Annual Conference breakout topics announced -- register by Jan. 31 and SAVE!

FDLI SmartBrief | Jan 18, 2017




Sign up for FDLI SmartBrief



Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more

Recent Poll view more polls


What affect do you think this year's media focus on imported drug, food and medical device product safety will have in 2010?

Chart.